Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    N5-(diaminomethylidene)ornithylprolylprolylglycylphenylalanylserylprolylphenylalanyl-N5-(diaminomethylidene)ornithine

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharvaris Closes $132.3M Share Offering
    Pharvaris Closes $132.3M Share Offering

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3292354/0/en/pharvaris-announces-closing-of-132-3-million-underwritten-offering-of-ordinary-shares-and-full-exercise-of-underwriters-option-to-purchase-additional-shares.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Deucrictibant IR+XR Combo Data Presented at CIIC 2026
    Deucrictibant IR+XR Combo Data Presented at CIIC 2026

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3276834/0/en/evidence-supporting-combined-use-of-deucrictibant-ir-with-deucrictibant-xr-presented-at-ciic-spring-2026-conference.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    Pharvaris Reports 2025 Financial Results And Business Update
    Pharvaris Reports 2025 Financial Results And Business Update

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267207/0/en/Pharvaris-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Deucrictibant Shows Promise in Bradykinin Angioedema Treatment
    Deucrictibant Shows Promise in Bradykinin Angioedema Treatment

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247196/0/en/Deucrictibant-Data-Supporting-Potentially-Differentiated-Profile-for-the-On-Demand-and-Prophylactic-Treatment-of-Bradykinin-Mediated-Angioedema-Presented-at-AAAAI-2026.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Pharvaris to Present Clinical Data at AAAAI 2026 Annual Meeting
    Pharvaris to Present Clinical Data at AAAAI 2026 Annual Meeting

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235142/0/en/Pharvaris-to-Present-Clinical-Data-at-the-AAAAI-2026-Annual-Meeting.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Pharvaris Outlines 2026 Strategic Priorities
    Pharvaris Outlines 2026 Strategic Priorities

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216675/0/en/Pharvaris-Outlines-2026-Strategic-Priorities.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.